Regeneron Pharmaceuticals Number of Shares Shorted vs. Price to Earnings To Growth Fundamental Analysis
Regeneron Pharmaceuticals is rated third in price to earnings to growth category among related companies. It is rated third in number of shares shorted category among related companies making about 1,194,737 of Number of Shares Shorted per Price to Earnings To Growth. PEG Ratio indicates potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate.Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates future growth of a firm. The low PEG ratio usually implies that equity instrument is undervalued; where as PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
|Price to Earnings To Growth ( times )|
|Number of Shares Shorted|
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect price of the stock.
Regeneron Pharmaceuticals Number of Shares Shorted Comparison
Number of Shares Shorted
Regeneron Pharmaceuticals Fundamental Comparison